Disclosures
FB is supported by the Berlin Institute of Health (BIH) and the Berlin
School of Mind and Brain, both unrelated to this review.
AL has no disclosures to report.
FCO receives research support from the American Academy of Neurology
(AAN) unrelated to this review.
CF receives research funding by the Deutsche Forschungsgemeinschaft
(DFG, German Research Foundation; grant numbers FI 2309/1-1 and FI
2309/2-1) and the German Ministry of Education and Research (BMBF, grant
number 01GM1908D; CONNECT-GENERATE) unrelated to this review.
FP is named as coinventors on the patent application for the foveal
shape analysis method (“Method for estimating shape parameters of the
fovea byoptical coherence tomography”, International Publication
Number: “WO 2019/016319 A1”), is a cofounder and hold shares in
technology start-up Nocturne GmbH, receives honoraria for lecturing, and
travel expenses for attending meetings from Guthy Jackson Foundation,
Bayer, Biogen, Merck Serono, Sanofi Genzyme, Novartis, Alexion, Viela
Bio, Roche, UCB, Mitsubishi Tanabe and Celgene. His research is funded
by the German Ministry for Education and Research (BMBF), Deutsche
Forschungsgemeinschaft (DFG), Einstein Foundation, Guthy Jackson
Charitable Foundation, EU FP7 Framework Program, Biogen, Genzyme, Merck
Serono, Novartis, Bayer, Alexion, Roche, Parexel and Almirall.
CC has received speaking fees from Bayer and research support from
Novartis unrelated to this review.